At1g63340 Antibody

What is At1g63340 and why is it important in plant research?

At1g63340 is a gene locus in Arabidopsis thaliana, encoding a flavin monooxygenase-like protein that plays a significant role in auxin biosynthesis and plant development. This gene belongs to the YUCCA family of genes, which catalyze a rate-limiting step in the tryptamine (TAM) pathway for auxin production .

The importance of At1g63340 stems from its involvement in:

• Auxin-mediated plant growth and development

• Root and hypocotyl elongation

• Vascular differentiation

• Floral organ development

Research on At1g63340 contributes to our understanding of fundamental plant hormone signaling pathways that regulate multiple aspects of growth and development .

How can I confirm the specificity of an At1g63340 antibody?

To confirm specificity of an At1g63340 antibody, you should implement a multi-faceted validation approach:

• Western blot analysis using:

  • Wild-type plant extracts (positive control)

  • At1g63340 knockout/knockdown mutants (negative control)

  • Recombinant At1g63340 protein (specificity control)

• Immunoprecipitation followed by mass spectrometry to identify pulled-down proteins

• Cross-reactivity testing against closely related YUCCA family proteins

• Immunohistochemistry comparing expression patterns with known transcript data

Always include proper controls in each experiment, including no primary antibody controls, isotype controls, and pre-absorbed antibody controls .

What sample preparation methods are recommended for At1g63340 antibody applications?

Optimization may be required for specific tissue types or developmental stages .

How should I design experiments to study At1g63340 expression in different plant tissues?

A comprehensive experimental design for studying At1g63340 expression should include:

• Tissue selection and collection strategy:

  • Sample multiple tissues (roots, stems, leaves, flowers, and developing fruits)

  • Collect at different developmental stages

  • Include both light and dark-grown seedlings to account for light regulation

• Technical approaches:

  • Western blot analysis for protein quantification

  • Immunohistochemistry for spatial localization

  • Quantitative immunoprecipitation for protein interaction studies

• Controls to include:

  • Positive control: Tissues known to express At1g63340 (e.g., roots based on auxin biosynthesis patterns)

  • Negative control: At1g63340 knockout mutants

  • Loading control: Anti-actin or anti-tubulin antibodies

  • Specificity control: Pre-absorption with recombinant At1g63340 protein

• Environmental variables to consider:

  • Light conditions (intensity, duration, quality)

  • Growth medium composition

  • Hormone treatments

  • Stress conditions

• Statistical design:

  • Minimum of 3-5 biological replicates

  • Technical replicates for each assay

  • Randomized sampling design

This design allows for robust characterization of At1g63340 expression patterns while minimizing experimental artifacts .

What are the critical parameters for optimizing an ELISA assay using At1g63340 antibodies?

Optimizing an ELISA assay for At1g63340 requires careful consideration of several parameters:

Follow a factorial experimental design to identify parameter interactions, particularly between antibody dilution and substrate incubation time, which have shown significant interactions in similar assays .

For optimal results, test antibody lot-to-lot variation, as this can significantly impact assay performance. Standard curve reproducibility, assay detection limits, and coefficient of variation should all be evaluated to determine optimal conditions .

How can I use At1g63340 antibodies to investigate protein-protein interactions in auxin signaling pathways?

Investigating protein-protein interactions involving At1g63340 requires sophisticated approaches:

• Co-immunoprecipitation (Co-IP):

  • Use anti-At1g63340 antibodies conjugated to magnetic beads

  • Extract proteins under native conditions from relevant tissues

  • Identify interaction partners through mass spectrometry

  • Confirm interactions with reciprocal Co-IP

• Proximity Ligation Assay (PLA):

  • Allows detection of protein interactions in situ

  • Requires two antibodies (anti-At1g63340 and antibody against potential interactor)

  • Provides spatial information about interaction sites within cells

  • Quantify interaction signals across different tissues or conditions

• Bimolecular Fluorescence Complementation (BiFC) validation:

  • Create fusion constructs of At1g63340 and potential partners

  • Transform plants and observe protein interactions in vivo

  • Use antibodies to confirm expression levels of fusion proteins

• Analysis methodology:

  • Compare interaction patterns across:

    • Different developmental stages

    • Hormone treatments (especially auxin)

    • Environmental stresses

  • Perform hierarchical clustering of interaction networks

  • Validate key interactions with genetic approaches (double mutants, etc.)

This multi-method approach provides robust evidence for true interaction partners while minimizing false positives that can occur with single methods .

What approaches should I use when At1g63340 antibody results conflict with transcriptomic data?

When antibody-based protein detection results conflict with transcriptomic data for At1g63340, a systematic troubleshooting approach is necessary:

• Verify antibody specificity:

  • Reconfirm using knockout/knockdown lines

  • Test for cross-reactivity with related YUCCA family proteins

  • Consider epitope accessibility in different experimental conditions

• Investigate post-transcriptional regulation:

  • Measure mRNA stability using actinomycin D chase experiments

  • Assess potential miRNA regulation

  • Examine alternative splicing that might affect epitope presence

• Analyze post-translational modifications:

  • Perform phosphorylation-specific Western blots

  • Use mass spectrometry to identify modifications

  • Test if modifications affect antibody recognition

• Examine protein stability and turnover:

  • Conduct cycloheximide chase experiments

  • Investigate proteasome-dependent degradation

  • Assess protein half-life under different conditions

• Reconciliation approach:

  • Create a temporal map comparing transcript and protein levels

  • Incorporate known delays between transcription and translation

  • Develop mathematical models accounting for synthesis and degradation rates

This comprehensive analysis can reveal important regulatory mechanisms governing At1g63340 expression and function that would be missed by examining either transcriptomic or proteomic data alone .

What are the advantages of using recombinant antibodies for At1g63340 compared to traditional antibodies?

Recombinant antibodies offer several significant advantages for At1g63340 research:

• Defined sequence and reproducibility:

  • Sequence-defined antibodies can be replicated with identical binding properties

  • Eliminates batch-to-batch variation common in animal-derived antibodies

  • Ensures experimental reproducibility across different studies

• Customizable properties:

  • Ability to modify binding affinity through directed mutation

  • Can add fusion tags for detection or purification

  • Option to create specialized formats (Fab fragments, bispecific antibodies)

• Selection under defined conditions:

  • Can select antibodies under the exact biochemical conditions of intended use

  • Ability to counter-select against related YUCCA family proteins

  • Reduces cross-reactivity problems

• Ethical considerations:

  • Eliminates need for animal immunization

  • Aligns with 3Rs principles (Replacement, Reduction, Refinement)

  • Complies with EU Directive 2010/63/EU recommendations

• Production advantages:

  • Faster production timeline (weeks vs. months)

  • Unlimited supply without further animal use

  • Consistent performance over time

Comparative performance data from studies on other plant proteins shows:

For studying complex plant signaling pathways involving At1g63340, these advantages make recombinant antibodies increasingly the preferred choice for researchers seeking reliable and reproducible results .

How can I develop recombinant antibodies against At1g63340 for my research?

Developing recombinant antibodies against At1g63340 involves several specialized steps:

• Antigen preparation:

  • Express recombinant At1g63340 protein (full-length or immunogenic fragments)

  • Consider using both native and denatured forms for selection

  • Ensure proper folding of the flavin monooxygenase domain

  • Purify to >90% homogeneity

• Library selection methods:

  • Phage display: Most common approach using large antibody libraries

  • Yeast display: Alternative with advantages for folded protein targets

  • Ribosome display: Useful for generating high-affinity binders

• Selection strategy:

  • Perform 3-4 rounds of selection with increasing stringency

  • Include counter-selection against related YUCCA family proteins

  • Screen for antibodies that work in multiple applications

  • Include positive and negative selection conditions mimicking experimental use

• Production optimization:

  • Test expression in multiple systems (E. coli, mammalian cells)

  • Optimize codon usage for expression system

  • Evaluate different purification strategies

  • Assess stability under storage conditions

For researchers without specialized equipment, several academic centers and companies offer custom recombinant antibody development services. Typical development costs range from $2,000-$5,000 USD, with timelines of 2-3 months for a completed project .

The resulting recombinant antibodies should be deposited in repositories like the Recombinant Antibodies & Mimetics Database with full sequence information to promote reproducibility in the research community .

What are common causes of non-specific binding with At1g63340 antibodies and how can they be resolved?

Non-specific binding is a common challenge when working with plant protein antibodies like those against At1g63340. Here are the primary causes and solutions:

For plant-specific considerations:

• Plant tissues often contain compounds that interfere with antibody binding

• PVPP (polyvinylpolypyrrolidone) addition to extraction buffers can reduce interference from phenolic compounds

• TCA/acetone precipitation of proteins before Western blotting can improve specificity

• Extended washing steps (5-6 washes of 10 minutes each) can significantly reduce background

How do I interpret and troubleshoot contradictory results from different application methods using At1g63340 antibodies?

When faced with contradictory results across different applications using At1g63340 antibodies, follow this systematic troubleshooting framework:

• Epitope accessibility analysis:

  • Western blot: Detects denatured epitopes

  • Immunoprecipitation: Requires native conformation

  • Immunohistochemistry: Affected by fixation and embedding

  Action: Test antibody against both native and denatured recombinant protein to determine epitope requirements

• Application-specific optimization:

  Application	Critical Parameters	Optimization Approach
  Western Blot	Denaturing conditions	Test reducing vs. non-reducing conditions
  	Transfer efficiency	Optimize transfer time/buffer for large proteins
  	Blocking agent	Compare BSA vs. milk vs. commercial blockers
  Immunoprecipitation	Buffer stringency	Test low vs. high salt conditions
  	Detergent type	Compare NP-40, Triton X-100, digitonin
  	Incubation time	Optimize antibody binding time
  Immunohistochemistry	Fixation method	Compare PFA, methanol, acetone fixation
  	Antigen retrieval	Test heat-induced vs. enzymatic retrieval
  	Detection system	Compare direct vs. amplified detection

• Reconciliation strategy:

  • Create a comparison matrix of results across methods

  • Identify patterns (e.g., works in denaturing but not native conditions)

  • Develop a unified model explaining discrepancies

  • Design targeted experiments to test the model

• Additional validation approaches:

  • Use multiple antibodies targeting different epitopes

  • Confirm with orthogonal methods (e.g., mass spectrometry)

  • Leverage genetic tools (knockout/knockdown lines)

  • Consider reporter gene fusions as alternative approach

When interpreting results, remember that different applications reveal different aspects of protein biology. Contradictions often provide valuable insights into protein conformation, interactions, or modifications that would be missed using a single approach .

How can new antibody technologies advance our understanding of At1g63340 function in plant development?

Emerging antibody technologies offer significant potential to advance At1g63340 research:

• Nanobodies (VHH antibodies):

  • Single-domain antibodies derived from camelid heavy chains

  • Smaller size (15 kDa) enables access to sterically hindered epitopes

  • Can penetrate dense plant tissues more effectively

  • Potential applications for At1g63340:

    • Intracellular targeting of specific protein pools

    • Super-resolution microscopy to visualize precise subcellular localization

    • In vivo modulation of protein activity

• Proximity-dependent labeling:

  • Antibody-enzyme fusions (APEX, BioID, TurboID)

  • Map protein interaction networks in native cellular environments

  • For At1g63340 research:

    • Identify transient interaction partners in auxin biosynthesis pathway

    • Map spatial organization of enzyme complexes

    • Detect temporal changes in protein associations during development

• Antibody-based biosensors:

  • Split fluorescent protein complementation

  • FRET/BRET-based detection systems

  • Potential to monitor:

    • At1g63340 conformational changes upon substrate binding

    • Real-time enzyme activity in living plants

    • Response to environmental stimuli or hormone treatments

• Engineered antibody-based inhibitors:

  • Designed to block specific protein domains or interactions

  • Can create chemical-genetic tools for conditional inhibition

  • Applications for At1g63340:

    • Domain-specific inhibition to map structure-function relationships

    • Tissue-specific inhibition using promoter-driven expression

    • Temporal control using inducible systems

These technologies could help resolve several outstanding questions about At1g63340 function:

• Precise catalytic mechanism in the auxin biosynthesis pathway

• Regulation of enzyme activity by post-translational modifications

• Temporal and spatial coordination with other YUCCA family members

• Integration with environmental and developmental signaling networks

What methodological advances are needed to improve At1g63340 antibody research reproducibility?

Improving reproducibility in At1g63340 antibody research requires systematic methodological advances in several areas:

• Standardized antibody validation protocols:

  • Implement minimum validation standards including:

    • Genetic knockout controls

    • Orthogonal detection methods

    • Cross-reactivity assessment against all YUCCA family members

    • Application-specific validation

  • Establish centralized validation repositories for plant antibodies

  • Develop standardized positive and negative control materials

• Improved reporting practices:

  • Comprehensive documentation of:

    • Complete antibody identification (catalog number, lot, RRID)

    • Detailed experimental conditions

    • All optimization steps and controls

    • Raw image data availability

  • Implement structured reporting formats in publications

• Technical improvements:

  • Quantitative approaches:

    • Absolute quantification using isotope-labeled standards

    • Digital PCR-equivalent methods for protein detection

    • AI-assisted image analysis for unbiased quantification

  • Multi-laboratory validation initiatives:

    • Ring trials for antibody performance

    • Collaborative projects testing the same antibodies across labs

• Training and education:

  • Develop specialized training in:

    • Plant-specific antibody techniques

    • Validation methods

    • Appropriate controls

    • Data interpretation and troubleshooting

  • Create accessible resources and protocols

These methodological advances would not only improve At1g63340 antibody research but would benefit the broader plant research community by establishing higher standards for antibody-based studies .